These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 22926826)

  • 1. Identifying novel spatiotemporal regulators of innate immunity.
    Victorino F; Alper S
    Immunol Res; 2013 Mar; 55(1-3):3-9. PubMed ID: 22926826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatiotemporal inhibition of innate immunity signaling by the Tbc1d23 RAB-GAP.
    De Arras L; Yang IV; Lackford B; Riches DW; Prekeris R; Freedman JH; Schwartz DA; Alper S
    J Immunol; 2012 Mar; 188(6):2905-13. PubMed ID: 22312129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of innate immunity receptors in the pathogenesis of inflammatory bowel disease.
    Elia PP; Tolentino YF; Bernardazzi C; de Souza HS
    Mediators Inflamm; 2015; 2015():936193. PubMed ID: 25821356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of innate immune molecules for a new class of drugs: infection, inflammation and beyond.
    Kimura HJ; Suzuki K; Landek-Salgado MA; Caturegli P; Jounai N; Kobiyama K; Takeshita F
    Endocr Metab Immune Disord Drug Targets; 2011 Mar; 11(1):68-75. PubMed ID: 21348819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
    Tartey S; Takeuchi O
    Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of toll-like receptor signaling by the SF3a mRNA splicing complex.
    O'Connor BP; Danhorn T; De Arras L; Flatley BR; Marcus RA; Farias-Hesson E; Leach SM; Alper S
    PLoS Genet; 2015 Feb; 11(2):e1004932. PubMed ID: 25658809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutic strategies based on toll-like receptor signaling.
    Lawton JA; Ghosh P
    Curr Opin Chem Biol; 2003 Aug; 7(4):446-51. PubMed ID: 12941417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A guide to miRNAs in inflammation and innate immune responses.
    Nejad C; Stunden HJ; Gantier MP
    FEBS J; 2018 Oct; 285(20):3695-3716. PubMed ID: 29688631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate recognition of microbial-derived signals in immunity and inflammation.
    Zhang Y; Liang C
    Sci China Life Sci; 2016 Dec; 59(12):1210-1217. PubMed ID: 27888386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of innate immune pathways in type 1 diabetes pathogenesis.
    Pino SC; Kruger AJ; Bortell R
    Curr Opin Endocrinol Diabetes Obes; 2010 Apr; 17(2):126-30. PubMed ID: 20125005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannose-binding lectin and innate immunity.
    Ip WK; Takahashi K; Ezekowitz RA; Stuart LM
    Immunol Rev; 2009 Jul; 230(1):9-21. PubMed ID: 19594626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity in inflammatory bowel disease: state of the art.
    Hisamatsu T; Ogata H; Hibi T
    Curr Opin Gastroenterol; 2008 Jul; 24(4):448-54. PubMed ID: 18622158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immune receptors in type 1 diabetes: the relationship to cell death-associated inflammation.
    Kim TK; Lee MS
    Biochem Soc Trans; 2020 Jun; 48(3):1213-1225. PubMed ID: 32510139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intervention of Toll-like receptor-mediated human innate immunity and inflammation by synthetic compounds and naturally occurring products.
    Fasciano S; Li L
    Curr Med Chem; 2006; 13(12):1389-95. PubMed ID: 16719784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases.
    Xu M; Liu PP; Li H
    Physiol Rev; 2019 Jan; 99(1):893-948. PubMed ID: 30565509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor of apoptosis (IAP) proteins in regulation of inflammation and innate immunity.
    Damgaard RB; Gyrd-Hansen M
    Discov Med; 2011 Mar; 11(58):221-31. PubMed ID: 21447281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of toll-like receptors in gastrointestinal inflammation.
    Ishihara S; Rumi MA; Ortega-Cava CF; Kazumori H; Kadowaki Y; Ishimura N; Kinoshita Y
    Curr Pharm Des; 2006; 12(32):4215-28. PubMed ID: 17100624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRAK family in inflammatory autoimmune diseases.
    Su LC; Xu WD; Huang AF
    Autoimmun Rev; 2020 Mar; 19(3):102461. PubMed ID: 31917263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When Rab GTPases meet innate immune signaling pathways.
    Su C; Zheng C
    Cytokine Growth Factor Rev; 2021 Jun; 59():95-100. PubMed ID: 33608190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.